Linda Molaison v. HHS - Pneumococcal, shoulder injury related to vaccine administration (SIRVA) (2025)
Case summary [AI summaries can sometimes make mistakes]
On October 18, 2022, Linda Molaison filed a petition alleging SIRVA after a Prevnar 13 pneumococcal conjugate vaccine administered on December 2, 2019. Respondent conceded that her injury was consistent with Table SIRVA and that the remaining requirements for compensation were met.
Chief Special Master Corcoran granted entitlement on September 5, 2024. The damages proffer, filed May 27, 2025, gives the compensation breakdown but does not lay out a detailed clinical story of onset, treatment, imaging, or witness testimony.
Ms. Molaison agreed to the proffered damages.
The Special Master awarded $185,425.33, consisting of $180,000.00 for pain and suffering and $5,425.33 for past unreimbursable expenses.
Theory of causation
Adult petitioner; Prevnar 13 pneumococcal conjugate vaccine December 2, 2019; Table SIRVA. COMPENSATED. Respondent conceded entitlement; public damages proffer lacks detailed clinical chronology. Entitlement September 5, 2024; damages May 27, 2025. Award $185,425.33 = $180,000.00 pain/suffering + $5,425.33 expenses. Petition filed October 18, 2022. Counsel: Jonathan Joseph Svitak, Shannon Law Group.
Source PDFs
USCOURTS-cofc-1_22-vv-01546